Peer-reviewedCC BY-NC-ND 4.0Australian Prescriber
Delgocitinib for chronic hand eczema
Related
- D-CARE (Delgocitinib-Chronic hAnd Eczema Response Evaluation): A Retrospective, Multicenter, Real-World Study of Patients with Chronic Hand Eczema (CHE) Treated with Delgocitinib 2% Cream—Temporal Analysis of Symptom and Clinical Sign Response
- Topical Delgocitinib for Capecitabine-Induced Hand–Foot Syndrome: A Therapeutic Option?
- Case Report: Clinical improvement of localized chronic eczema following multisegmental paraspinal electroacupuncture
- Clinical Outcomes in a Longitudinal Virtual Dermatology Care Model for Eczema and Psoriasis.
- Dermoscopic clues for differentiating mycosis fungoides palmaris et plantaris from palmoplantar eczema.
BibTeX
@article{anon2026delgocitinib,
title = {{Delgocitinib for chronic hand eczema}},
journal = {Australian Prescriber},
year = {2026},
month = oct,
doi = {10.18773/austprescr.2026.037},
url = {https://doi.org/10.18773/austprescr.2026.037},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Delgocitinib for chronic hand eczema
PY - 2026
DA - 2026/10/01
JO - Australian Prescriber
DO - 10.18773/austprescr.2026.037
UR - https://doi.org/10.18773/austprescr.2026.037
SN - 0312-8008
SN - 1839-3942
ER -